Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2022 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Other Operating Expenses of $2.6 million for Q1 2026, up 197.51% year-over-year from $885000.0 in Q1 2025, and up 225.8% quarter-over-quarter from -$2.1 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2022 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Other Operating Expenses history runs 4 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 197.51% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at -$10.2 million (down 127.65% YoY), while the FY2025 annual figure was $1.3 million, up 419.43% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2.6 million, up from -$2.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $52.1 million in Q3 2024, with the low at -$11.8 million in Q2 2024.
- The 4-year median for Other Operating Expenses is -$2.1 million (2025), against an average of $4.5 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses slumped 113.44% in 2025, then soared 197.51% in 2026.
- Syndax Pharmaceuticals' Other Operating Expenses stood at $13.7 million in 2022, then tumbled by 132.15% to -$4.4 million in 2024, then jumped by 52.6% to -$2.1 million in 2025, then surged by 225.8% to $2.6 million in 2026.
- Business Quant data shows SNDX's Other Operating Expenses at $2.6 million in Q1 2026, -$2.1 million in Q4 2025, and -$7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.66 Mn |
| Mar 31, 2026 | 2.63 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | -7.01 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Mar 31, 2025 | 885,000.00 |
| Dec 31, 2024 | -4.42 Mn |
| Sep 30, 2024 | 52.12 Mn |
| Jun 30, 2024 | -11.77 Mn |
| Jun 30, 2022 | 13.73 Mn |